IMR Press / FBL / Volume 20 / Issue 7 / DOI: 10.2741/4358

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Role of microRNAs in hepatocellular carcinoma
Show Less
1 Department of Medical Ultrasound, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, 200072, Shanghai, China
2 Department of Nuclear Medicine, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, PR China
Academic Editor:Wei Qin
Front. Biosci. (Landmark Ed) 2015, 20(7), 1056–1067; https://doi.org/10.2741/4358
Published: 1 June 2015
(This article belongs to the Special Issue MicroRNA in hepatic fibrosis and cirrhosis)
Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer related death worldwide. HCC develops through a multistep process that involves genetic and epigenetic changes. In addition to genetic and epigenetic mechanisms, recent studies have shown that microRNAs (miRNAs) play essential roles in hepatocellular carcinogenesis through the post-transcriptional regulation of tumor associated-genes. In this review, we summarize the role of miRNAs in HCC and its microenvironment, and discuss the implications for HCC therapy.

Keywords
HCC
microenvironment
miRNA
therapy
Share
Back to top